Atezolizumab - 28 Day Cycle Clinical Trials

1 actively recruiting trial across 1 location

Also known as: L01XC32, Tecentriq

Filter by location:

Duarte, California1 trial

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

City of Hope Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.